TENX
TENAX THERAPEUTICS, INC. · Healthcare · Market cap $65.9M
Insiders bought $6.4M net in the last 90 days ·0 sellers, 4 buyers· latest Form 4 filed Oct 21, 2026
Insider Buying
$6.6M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Oct 21, 2026
ADAR1 Capital Management, LLC
TENAX THERAPEUTICS, INC. (TENX) has 15 SEC Form 4 filings (32 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Oct 21, 2026.
Inside the rolling window, 7 insiders at TENAX THERAPEUTICS, INC. reported 25 open-market purchases totaling $6.6M and no open-market sales. The most active filer is 10% Owner ADAR1 Capital Management, LLC with 10 filings. Insiders have net bought $6.4M over the trailing 6 months. The largest single insider purchase in this window was $1.6M by 10% Owner ADAR1 Capital Management, LLC on Sep 3, 2026. The most recent open-market filing is a purchase of 336,528 shares by 10% Owner ADAR1 Capital Management, LLC, dated Oct 19, 2026, worth $507K.
- Industry:Biotechnology
- CEO:Christopher T. Giordano
- Employees:15
- HQ:Chapel Hill, NC, US
- IPO:1994-04-04
| Source | |||||||
|---|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 336,528 | $507K | Oct 21 | cluster+8.0% | SEC ↗ | |
| 10% Owner | Purchase | 254,342 | $406K | Oct 21 | cluster+8.0% | SEC ↗ | |
| 10% Owner | Purchase | 331,979 | $551K | Oct 21 | cluster+8.0% | SEC ↗ | |
Doogan DeclanFirst filing | Director | Purchase | 53,000 | $102K | Sep 18 | cluster-7.4% | SEC ↗ |
Giordano Christopher ThomasFirst in 10 months | CEO | Purchase | 6,000 | $11K | Sep 16 | cluster-3.3% | SEC ↗ |
Giordano Christopher ThomasFirst in 10 months | CEO | Purchase | 4,850 | $9K | Sep 16 | cluster-3.3% | SEC ↗ |
STAAB THOMAS R IIFirst filing | Chief Financial Officer | Purchase | 5,675 | $11K | Sep 16 | cluster-3.3% | SEC ↗ |
| 10% Owner | Purchase | 900,000 | $1.6M | Sep 8 | cluster-11.1% | SEC ↗ | |
| 10% Owner | Purchase | 403,571 | $723K | Sep 2 | cluster-4.9% | SEC ↗ | |
| 10% Owner | Purchase | 179,058 | $322K | Sep 2 | cluster-4.9% | SEC ↗ | |
| 10% Owner | Purchase | 187,704 | $338K | Sep 2 | — | SEC ↗ | |
| 10% Owner | Purchase | 202,124 | $360K | Aug 24 | — | SEC ↗ | |
| 10% Owner | Purchase | 716,369 | $1.3M | Aug 24 | — | SEC ↗ | |
| 10% Owner | Purchase | 107,374 | $188K | Aug 24 | — | SEC ↗ | |
| Chief Medical Officer | Purchase | 2,500 | $25K | Dec 10 | — | SEC ↗ | |
| Chief Medical Officer | Purchase | 2,500 | $26K | Dec 10 | — | SEC ↗ | |
Rich StuartFirst filing | Chief Medical Officer | Purchase | 1,000 | $9K | Dec 5 | — | SEC ↗ |
Rich StuartFirst filing | Chief Medical Officer | Purchase | 1,500 | $14K | Dec 5 | — | SEC ↗ |
Rich StuartFirst filing | Chief Medical Officer | Purchase | 2,500 | $23K | Dec 5 | — | SEC ↗ |
Giordano Christopher ThomasFirst filing | CEO | Purchase | 1,612 | $13K | Nov 20 | — | SEC ↗ |
Giordano Christopher ThomasFirst filing | CEO | Purchase | 455 | $3K | Nov 20 | — | SEC ↗ |
Giordano Christopher ThomasFirst filing | CEO | Purchase | 538 | $4K | Nov 20 | — | SEC ↗ |
| Director | Purchase | 93 | $665 | Nov 20 | — | SEC ↗ | |
| Director | Purchase | 1,900 | $14K | Nov 20 | — | SEC ↗ | |
MCGAULEY THOMASFirst filing | Interim CFO | Purchase | 8,000 | $58K | Nov 19 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does TENX have?
TENAX THERAPEUTICS, INC. (TENX) has 15 SEC Form 4 filings (32 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Oct 21, 2026.
When was the most recent SEC Form 4 filing for TENX?
The most recent Form 4 filing for TENX on Tracefour is dated Oct 21, 2026.
Who is the most active insider at TENX?
The most active SEC Form 4 filer at TENX in the rolling window is 10% Owner ADAR1 Capital Management, LLC, with 10 filings.
What is the net insider flow at TENX over the last 6 months?
Over the trailing 180 days, insiders at TENX have net bought $6.4M based on SEC Form 4 disclosures.
What was the largest insider purchase at TENX?
The largest single insider open-market purchase at TENX in the rolling window was $1.6M by 10% Owner ADAR1 Capital Management, LLC on 2026-09-03.
What is the total insider buy and sell value at TENX in the current window?
Inside the rolling window, insiders at TENX bought $6.6M and sold $0 based on SEC Form 4 filings.
Can I get alerts for TENX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at TENAX THERAPEUTICS, INC. (TENX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
TENAX THERAPEUTICS, INC. is in the Healthcare sector.